
Genetic Testing for Breast & Ovarian
Genetic predisposition is a primary risk factor for hereditary breast and ovarian cancers. Utilizing Next-Generation Sequencing (NGS), this test comprehensively analyzes BRCA1 and BRCA2 genes, along with 24 additional genes associated with hereditary cancer risks (26 genes in total). By identifying pathogenic gene mutations early, this screening empowers individuals to formulate personalized preventative care, heightened surveillance plans, and proactive risk management strategies.
🎯Recommended For:
- Individuals with a personal or family history of breast, ovarian
- Related cancers (especially early-onset cases), relatives of known BRCA mutation carriers
- Women seeking proactive genetic health profiling.
SHCP-Breast/ Ovarian Cancer-26
$3,800
Contact Us
Working Hours
Monday to Friday:9 am – 6 pm
Saturday:9 am – 1 pm
Sunday and Public Holiday:Closed
eHealth System & Health Care Voucher
We can upload images to eHRSS.
We support the use of Health Care Voucher.




